1-2 of 2
Song Mu
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Pamiparib Monotherapy for Patients with Germline BRCA1/2-Mutated Ovarian Cancer Previously Treated with at Least Two Lines of Chemotherapy: A Multicenter, Open-Label, Phase II Study

Open Access
Xiaohua Wu, Jianqing Zhu, Jing Wang, Zhongqiu Lin, Rutie Yin, Wei Sun, Qi Zhou, Songling Zhang, Danbo Wang, Hong Shi, Yunong Gao, Yi Huang, Guiling Li, Xiuli Wang, Ying Cheng, Ge Lou, Qinglei Gao, Li Wang, Xiuping Du, Mei Pan, Xiyan Mu, Li Li, Miao Li, Song Mu, Beihua Kong
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (4): 653–661.
https://doi.org/10.1158/1078-0432.CCR-21-1186
Published: 15 February 2022
View article titled, Pamiparib Monotherapy for Patients with Germline BRCA1/2-Mutated Ovarian Cancer Previously Treated with at Least Two Lines of Chemotherapy: A Multicenter, Open-Label, Phase II Study
Open the PDF for Pamiparib Monotherapy for Patients with Germline BRCA1/2-Mutated Ovarian Cancer Previously Treated with at Least Two Lines of Chemotherapy: A Multicenter, Open-Label, Phase II Study in another window
Includes: Supplementary data
Journal Articles

The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Oral Doses of CH4987655 in Healthy Volunteers: Target Suppression Using a Biomarker

Free
Lucy Lee, Huifeng Niu, Ruediger Rueger, Yuriko Igawa, Jonathan Deutsch, Nobuya Ishii, Song Mu, Yuuichiro Sakamoto, Rachel Busse-Reid, Claude Gimmi, Petra Goelzer, Stefanie De Schepper, Yashushi Yoshimura, Joanne Barrett, Yuji Ishikawa, Georges Weissgerber, Richard Peck
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (23): 7368–7374.
https://doi.org/10.1158/1078-0432.CCR-09-1696
Published: 30 November 2009
View article titled, The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Oral Doses of CH4987655 in Healthy Volunteers: Target Suppression Using a Biomarker
Open the PDF for The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Oral Doses of CH4987655 in Healthy Volunteers: Target Suppression Using a Biomarker in another window